Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters-kluwer-health/a-new-rash-differential-iT0Bd7x00n
References (20)
-
Giulia Daneshgaran, D. Dubin, Daniel Gould (2020)
Cutaneous Manifestations of COVID-19: An Evidence-Based ReviewAmerican Journal of Clinical Dermatology, 21
-
Bourgonje (2020)
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)The Journal of Pathology, 251
-
(SachdevaM.GianottiR.ShahM.BradaniniL.TosiD.VeraldiS.Dodiuk-GadR. P. (2020). Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. Journal of Dermatologic Science, 98(2), 75–81. doi:10.1016/j.jdermsci.2020.04.011)
SachdevaM.GianottiR.ShahM.BradaniniL.TosiD.VeraldiS.Dodiuk-GadR. P. (2020). Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. Journal of Dermatologic Science, 98(2), 75–81. doi:10.1016/j.jdermsci.2020.04.011SachdevaM.GianottiR.ShahM.BradaniniL.TosiD.VeraldiS.Dodiuk-GadR. P. (2020). Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. Journal of Dermatologic Science, 98(2), 75–81. doi:10.1016/j.jdermsci.2020.04.011, SachdevaM.GianottiR.ShahM.BradaniniL.TosiD.VeraldiS.Dodiuk-GadR. P. (2020). Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. Journal of Dermatologic Science, 98(2), 75–81. doi:10.1016/j.jdermsci.2020.04.011
-
(ZhaoQ.FangX.PangZ.ZhangB.LiuH.ZhangF. (2020). COVID-19 and cutaneous manifestations: A systematic review. Journal of the European Academy of Dermatology and Venereology, 34(11), 2505–2510. doi:10.1111/jdv.1677832594572)
ZhaoQ.FangX.PangZ.ZhangB.LiuH.ZhangF. (2020). COVID-19 and cutaneous manifestations: A systematic review. Journal of the European Academy of Dermatology and Venereology, 34(11), 2505–2510. doi:10.1111/jdv.1677832594572ZhaoQ.FangX.PangZ.ZhangB.LiuH.ZhangF. (2020). COVID-19 and cutaneous manifestations: A systematic review. Journal of the European Academy of Dermatology and Venereology, 34(11), 2505–2510. doi:10.1111/jdv.1677832594572, ZhaoQ.FangX.PangZ.ZhangB.LiuH.ZhangF. (2020). COVID-19 and cutaneous manifestations: A systematic review. Journal of the European Academy of Dermatology and Venereology, 34(11), 2505–2510. doi:10.1111/jdv.1677832594572
-
(BourgonjeA. R.AbdulleA. E.TimensW.HillebrandsJ.NavisG. J.GordijnS. J.van GoorH. (2020). Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). The Journal of Pathology, 251(3), 228–248. doi:10.1002/path.547132418199)
BourgonjeA. R.AbdulleA. E.TimensW.HillebrandsJ.NavisG. J.GordijnS. J.van GoorH. (2020). Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). The Journal of Pathology, 251(3), 228–248. doi:10.1002/path.547132418199BourgonjeA. R.AbdulleA. E.TimensW.HillebrandsJ.NavisG. J.GordijnS. J.van GoorH. (2020). Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). The Journal of Pathology, 251(3), 228–248. doi:10.1002/path.547132418199, BourgonjeA. R.AbdulleA. E.TimensW.HillebrandsJ.NavisG. J.GordijnS. J.van GoorH. (2020). Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). The Journal of Pathology, 251(3), 228–248. doi:10.1002/path.547132418199
-
(GottliebM.LongB. (2020). Dermatologic manifestations and complications of COVID-19. American Journal of Emergency Medicine, 38(9), 1715–1721. doi:10.1016/j.ajem.2020.06.011)
GottliebM.LongB. (2020). Dermatologic manifestations and complications of COVID-19. American Journal of Emergency Medicine, 38(9), 1715–1721. doi:10.1016/j.ajem.2020.06.011GottliebM.LongB. (2020). Dermatologic manifestations and complications of COVID-19. American Journal of Emergency Medicine, 38(9), 1715–1721. doi:10.1016/j.ajem.2020.06.011, GottliebM.LongB. (2020). Dermatologic manifestations and complications of COVID-19. American Journal of Emergency Medicine, 38(9), 1715–1721. doi:10.1016/j.ajem.2020.06.011
-
P. Gisondi, S. Piaserico, C. Bordin, M. Alaibac, G. Girolomoni, L. Naldi (2020)
Cutaneous manifestations of SARS‐CoV‐2 infection: a clinical updateJournal of the European Academy of Dermatology and Venereology, 34
-
Malika Ladha, Nadia Luca, C. Constantinescu, Karen Naert, M. Ramien (2020)
Approach to Chilblains During the COVID-19 PandemicJournal of Cutaneous Medicine and Surgery, 24
-
AlSamman (2020)
Non-respiratory presentations of COVID-19, a clinical reviewAmerican Journal of Emergency Medicine, 38
-
Farnoosh Seirafianpour, Sogand Sodagar, Arash Mohammad, Parsa Panahi, Samaneh Mozafarpoor, S. Almasi, A. Goodarzi (2020)
Cutaneous manifestations and considerations in COVID‐19 pandemic: A systematic reviewDermatologic Therapy, 33
-
(LadhaM. A.LucaN.ConstantinescuC.NaertK.RamienM. L. (2020). Approach to chilblains during the COVID-19 pandemic. Journal of Cutaneous Medicine and Surgery, 24(5), 504–517. doi:10.1177/120347542093797832741218)
LadhaM. A.LucaN.ConstantinescuC.NaertK.RamienM. L. (2020). Approach to chilblains during the COVID-19 pandemic. Journal of Cutaneous Medicine and Surgery, 24(5), 504–517. doi:10.1177/120347542093797832741218LadhaM. A.LucaN.ConstantinescuC.NaertK.RamienM. L. (2020). Approach to chilblains during the COVID-19 pandemic. Journal of Cutaneous Medicine and Surgery, 24(5), 504–517. doi:10.1177/120347542093797832741218, LadhaM. A.LucaN.ConstantinescuC.NaertK.RamienM. L. (2020). Approach to chilblains during the COVID-19 pandemic. Journal of Cutaneous Medicine and Surgery, 24(5), 504–517. doi:10.1177/120347542093797832741218
-
(DaneshgaranG.DubinD. P.GouldD. J. (2020). Cutaneous manifestations of COVID-19: An evidence-based review. American Journal of Dermatology, 21(5), 627–639. doi:10.1007/s40257-020-00558-4)
DaneshgaranG.DubinD. P.GouldD. J. (2020). Cutaneous manifestations of COVID-19: An evidence-based review. American Journal of Dermatology, 21(5), 627–639. doi:10.1007/s40257-020-00558-4DaneshgaranG.DubinD. P.GouldD. J. (2020). Cutaneous manifestations of COVID-19: An evidence-based review. American Journal of Dermatology, 21(5), 627–639. doi:10.1007/s40257-020-00558-4, DaneshgaranG.DubinD. P.GouldD. J. (2020). Cutaneous manifestations of COVID-19: An evidence-based review. American Journal of Dermatology, 21(5), 627–639. doi:10.1007/s40257-020-00558-4
-
Qing Zhao, Xiaokai Fang, Zheng Pang, Bowen Zhang, Hong Liu, Furen Zhang (2020)
COVID‐19 and cutaneous manifestations: a systematic reviewJournal of the European Academy of Dermatology and Venereology, 34
-
(SeirafianpourF.SodagarS.MohammadA. P.PanahiP.MozafarpoorS.AlmasiS.GoodarziA. (2020). Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review. Dermatologic Therapy, e13986. doi:10.1111/dth.13986)
SeirafianpourF.SodagarS.MohammadA. P.PanahiP.MozafarpoorS.AlmasiS.GoodarziA. (2020). Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review. Dermatologic Therapy, e13986. doi:10.1111/dth.13986SeirafianpourF.SodagarS.MohammadA. P.PanahiP.MozafarpoorS.AlmasiS.GoodarziA. (2020). Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review. Dermatologic Therapy, e13986. doi:10.1111/dth.13986, SeirafianpourF.SodagarS.MohammadA. P.PanahiP.MozafarpoorS.AlmasiS.GoodarziA. (2020). Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review. Dermatologic Therapy, e13986. doi:10.1111/dth.13986
-
(GisondiP.PlasericoS.BordinC.AlaibacM.GirolomoniG.NaldiL. (2020). Cutaneous manifestation of SARS-CoV-2 infection: A clinical update. Journal of the European Academy of Dermatology and Venereology, 34(11), 2499–2504. doi:10.1111/jdv.1677432585074)
GisondiP.PlasericoS.BordinC.AlaibacM.GirolomoniG.NaldiL. (2020). Cutaneous manifestation of SARS-CoV-2 infection: A clinical update. Journal of the European Academy of Dermatology and Venereology, 34(11), 2499–2504. doi:10.1111/jdv.1677432585074GisondiP.PlasericoS.BordinC.AlaibacM.GirolomoniG.NaldiL. (2020). Cutaneous manifestation of SARS-CoV-2 infection: A clinical update. Journal of the European Academy of Dermatology and Venereology, 34(11), 2499–2504. doi:10.1111/jdv.1677432585074, GisondiP.PlasericoS.BordinC.AlaibacM.GirolomoniG.NaldiL. (2020). Cutaneous manifestation of SARS-CoV-2 infection: A clinical update. Journal of the European Academy of Dermatology and Venereology, 34(11), 2499–2504. doi:10.1111/jdv.1677432585074
-
M. Sachdeva, R. Gianotti, M. Shah, Lucia Bradanini, D. Tosi, S. Veraldi, M. Ziv, E. Leshem, R. Dodiuk-Gad (2020)
Cutaneous manifestations of COVID-19: Report of three cases and a review of literatureJournal of Dermatological Science, 98
-
For more than 101 additional continuing professional development articles related to Emergency Care topics -
Biomarker signatures in pathophysiology and therapeutic interventions in inflammatory bowel diseases -
M. Gottlieb, B. Long (2020)
Dermatologic manifestations and complications of COVID-19The American Journal of Emergency Medicine, 38
-
(AlSammanM.CaggiulaA.GanguliS.MisakM.PourmandA. (2020). Non-respiratory presentations of COVID-19, a clinical review. American Journal of Emergency Medicine, 38(11), 2444–2454. doi:10.1016/j.ajem.2020.09.054)
AlSammanM.CaggiulaA.GanguliS.MisakM.PourmandA. (2020). Non-respiratory presentations of COVID-19, a clinical review. American Journal of Emergency Medicine, 38(11), 2444–2454. doi:10.1016/j.ajem.2020.09.054AlSammanM.CaggiulaA.GanguliS.MisakM.PourmandA. (2020). Non-respiratory presentations of COVID-19, a clinical review. American Journal of Emergency Medicine, 38(11), 2444–2454. doi:10.1016/j.ajem.2020.09.054, AlSammanM.CaggiulaA.GanguliS.MisakM.PourmandA. (2020). Non-respiratory presentations of COVID-19, a clinical review. American Journal of Emergency Medicine, 38(11), 2444–2454. doi:10.1016/j.ajem.2020.09.054
- Publisher
- Wolters Kluwer Health
- Copyright
- © 2021 Wolters Kluwer Health, Inc. All rights reserved.
- ISSN
- 1931-4485
- eISSN
- 1931-4493
- DOI
- 10.1097/TME.0000000000000336
- Publisher site
- See Article on Publisher Site
Abstract
The CoVID-19 pandemic has impacted all areas of health care, especially emergency medicine. Most commonly, CoVID-19 is associated with respiratory and typical viral presentations. However, nonrespiratory presentations are becoming more common. Reported CoVID-19 dermatological changes include maculopapular and urticarial rashes, chilblain-like and livedo reticularis discolorations, and less commonly vesicular and petechial rashes. As frontline clinicians, emergency nurse practitioners should be aware of these skin findings to recognize potentially infected and otherwise asymptomatic patients. Early recognition could potentially lead to an earlier diagnosis and limit the spread of severe acute respiratory syndrome coronavirus 2.
Journal
Advanced Emergency Nursing Journal – Wolters Kluwer Health
Published: Jan 1, 2021